Just my musings ,but it makes sense to me that the company may want to strike a deal re a partnership at the commencement of the ph3 trial,rather than part way through,hence the time passed approx 3 months ,since ph2 trial completion ,from what I can gather ,there’s been no change to trial completion in May.Here’s hoping there in the process of speaking with and or finalising partnership negotiations with a possible suitor.Along with holding talks with the regulators,EMA and FDA.
DYOR
CHECKPOINT INHIBITORS - What The?, page-5
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $551.9M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $1.296M | 3.401M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54900 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 22008 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |